Topic Discussed : Global Cell Therapy Market

Speaker: Aarti Chitale

Key Takeaways:

1. This report covers the key trends and opportunities across the global cell therapy market. Some of the key areas being covered under the market include, industry trends, manufacturing automation, combination therapies and other future trends 
2. The report also highlights some of the emerging business models benefiting the market as well as the key drivers and restraints affecting the market growth
3. With the changing market landscape, Big pharma/bio-pharma players, are looking towards the adoption of a collaborative business approach by either entering into co-development/ co-commercialization agreements or acquiring smaller niche players so as to achieve competitive advantage with respect to specific therapy area or technology
4. Additionally, in order to cater to the pricing needs of these high value therapies, the companies are adopting a pay for performance model which allows the payer to make a payment basis the therapeutic outcome of the novel therapy
5. Kymriah and yescarta are amongst the first such CAR-T cell therapies with this arrangement. Also, there is a large scale adoption of risk sharing, fast to market models, which supports the development of these novel therapies

For further insights, please join us for future podcasts and become a member of Frost & Sullivan’s Leadership Council by emailing us at: [email protected] or click here to Contact Us.

Related Keywords: Frost & Sullivan, Regenerative Medicine, Combination Therapies, Cell-Gene therapies, Stem Cell Therapies, Mesenchymal Stem Cells, Adipose Derived Stem Cells, Induced Pluripotent Stem Cells, European Medicines Agency, Food and Drug Administrations, Act for Safety of Regenerative Medicine, Pharmaceutical and Medical Devices Act, CRISPR/Cas9, ACR-T Cell Therapies, Kymriah, Yescarta, Gilead Sciences, Novartis, Mergers and Acquisitions, Genome Editing, Curative Therapies, Nano-medicine, Alternative payment Models, One-time Payment Model, Annuity Payment Model, Value Based Payment Model, Autologous Stem Cells, Allogeneic Stem Cells, Fast to Market Model, Risk Sharing Model, In-House Development, Competitive Playbook, Conditional Approval, Oncology, Neurology, Cardiovascular Diseases, Dermatology, Muscoloskeletal, Immunology

Website: www.frost.com

Hosted on Acast. See acast.com/privacy for more information.